You are here

Foamix

FDA approval lets Foamix set its maiden acne therapy on course for US market launch

Endpoints

Mon, 10/21/19 - 09:58 am

The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict

Yahoo/Benzinga

Sun, 10/20/19 - 05:18 pm

Gilead Sciences

Edwards Lifesciences

Baxter International

Integra LifeSciences

Phathom Pharmaceuticals

Eton Pharmaceuticals

Melinta Therapeutics

Ligand Pharmaceuticals

Approval in sight, Perceptive, OrbiMed double down on Foamix's antibiotic foam to the tune of $64M

Endpoints

Tue, 07/30/19 - 11:27 am

Perceptive Advisors

A Foamix acne drug PhIII bombs, sending shares into a tailspin

Endpoints

Mon, 03/27/17 - 10:33 am

Top 6 BioPharma Movers of the Week

24/7 Wall St

Sat, 12/5/15 - 12:49 pm

Aeterna Zentaris

Arena Pharmaceuticals

Invivo Therapeutics

Foamix Announces Phase II Clinical Trial of Topical Minocycline Foam for Rosacea

PR-USA.net

Sat, 01/22/11 - 10:43 am

Foamix Receives a New U.S. Patent for Its Emollient and Aqueous Foam Technology

PR.com

Sat, 05/1/10 - 11:09 am